Novel Biomarkers Related Xuebijing Injection Improves Sepsis

Not yet recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

March 30, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Sepsis
All Listed Sponsors
lead

Southeast University, China

OTHER

NCT06920420 - Novel Biomarkers Related Xuebijing Injection Improves Sepsis | Biotech Hunter | Biotech Hunter